How has been the historical performance of Torrent Pharma?

Answer:The historical performance of Torrent Pharma shows a consistent growth trajectory in net sales and profitability over the years.

Breakdown:
Torrent Pharma's net sales have steadily increased from INR 7,673.00 crore in March 2019 to INR 11,516.00 crore in March 2025. The total operating income followed a similar trend, reaching INR 11,516.00 crore in March 2025, up from INR 8,508.00 crore in March 2022. The company's operating profit (PBDIT) also demonstrated significant growth, rising from INR 2,041.00 crore in March 2019 to INR 3,744.00 crore in March 2025, reflecting an operating profit margin of 32.88% in the latest fiscal year. Profit before tax increased from INR 562.00 crore in March 2019 to INR 2,673.00 crore in March 2025, while profit after tax rose to INR 1,911.00 crore from INR 436.00 crore over the same period. The company's total assets increased from INR 13,576.53 crore in March 2020 to INR 14,395.59 crore in March 2025, with total liabilities slightly decreasing from INR 14,505.45 crore in March 2024 to INR 14,395.59 crore in March 2025. Cash flow from operating activities was INR 2,585.00 crore in March 2025, although the net cash outflow for the year was INR 261.00 crore. Overall, Torrent Pharma's financial performance indicates a robust growth pattern in sales and profitability, alongside a stable asset base.